Search for the latest oncology news by tumour type
With the NRL State of Origin set to kick off in Sydney, Australians are being…
The Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) reports the three-year…
The Australian-led clinical trial ENZAMET has shown that the addition of hormone therapy with a…
A drug combination targeting multiple mutant versions of cancer’s ‘death star’ protein has shown promise…
In patients with stage II colon cancer where cancer DNA was not present in the…
Results of a Phase II clinical trial led by Cedars-Sinai Cancer investigators indicate that an immunotherapy drug…
Two targeted therapies, dabrafenib (taflinar) plus trametinib (mekinst), significantly increased the overall response rate compared to…
Based on guidance from biomarker screening, patients who are 55 years of age and older…
Immunotherapy has had limited success so far against glioblastoma, the most common and aggressive form…
Use of high-dose ifosfamide (Ifex) was found to be superior for treating recurrent and primary refractory…